SEC Comment Letter 0000000000-23-008953 to Orchard Therapeutics plc (CIK 0001748907)
Orchard Therapeutics plc (CIK 0001748907)
Date: Aug. 16, 2023 · CIK: 0001748907 · Accession: 0000000000-23-008953
AI Filing Summary & Sentiment
File numbers found in text: 333-273891
Letter
United States securities and exchange commission logo August 16, 2023 Bobby Gaspar Chief Executive Officer Orchard Therapeutics plc 245 Hammersmith Road London W6 8PW United Kingdom Re:Orchard Therapeutics plc Registration Statement on Form S-3 Filed August 10, 2023 File No. 333-273891 Dear Bobby Gaspar: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Catherine Magazu
Show Raw Text
United States securities and exchange commission logo
August 16, 2023
Bobby Gaspar
Chief Executive Officer
Orchard Therapeutics plc
245 Hammersmith Road
London W6 8PW
United Kingdom
Re:Orchard Therapeutics plc
Registration Statement on Form S-3
Filed August 10, 2023
File No. 333-273891
Dear Bobby Gaspar:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alan Campbell at 202-551-4224 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Catherine Magazu